BIOLARGO, INC. (BLGO)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-05-06

Key Insights

CEO Dennis P. Calvert conducted a town hall session on Discord on May 5, 2026, indicating the company is actively engaging with retail investors through alternative communication channels rather than traditional investor relations methods.
The filing is purely a Regulation FD Disclosure (Item 7.01) with no material business developments, financial results, or strategic announcements reported, suggesting this is routine investor communication rather than significant corporate news.
The company explicitly disclaimed liability for the disclosed information under Securities Act provisions, stating it is not 'filed' for purposes of Section 18 and will not be incorporated into future SEC filings, limiting the legal weight of statements made during the town hall.

Insider Trading Filed: 2026-04-02

Key Insights

The reporting person, Kenneth Reay Code, acquired 69,444 shares of BioLargo, Inc. (BLGO) common stock at a price of $0.162 per share, increasing his direct beneficial ownership to 25,875,752 shares.
The acquired shares are subject to a lock-up agreement, restricting their sale until the company reports at least $40 million in consolidated gross revenue, reaches a market capitalization of $300 million, or experiences a change in control.
The share acquisition was in exchange for a reduction in amounts owed by the company to the reporting person for salary and unreimbursed business expenses.

Current Report Filed: 2026-03-25

Key Insights

BioLargo, Inc. has entered into a $10 million common stock purchase agreement with Clearthink Capital Partners, LLC, providing the company with additional funding and flexibility to support its operations and growth.
The agreement allows BioLargo to sell shares to Clearthink at its discretion over a 36-month period, subject to certain limitations and conditions, including the effectiveness of a related registration statement.
The proceeds from these share sales will be used for working capital and general corporate purposes, potentially supporting the company's ongoing development and commercialization efforts.

Current Report Filed: 2026-03-05

Key Insights

BioLargo, Inc. announced plans to present a slide deck at an investor conference on March 5, 2026, providing an opportunity for the company to share updates and insights with the investment community.
The company also published a press release on March 5, 2026, potentially highlighting important developments or milestones that could impact the stock's performance.
As an OTCQX-listed company, BioLargo's share price and trading activity may be influenced by investor sentiment and market reaction to the information disclosed in the 8-K filing.

Annual Report Filed: 2026-03-04

Key Insights

The company has processes in place to assess, identify, and manage material cybersecurity risks, which are integrated into its overall risk management systems.
The company relies on information technology managed service providers (MSPs) to manage its computer and information systems and evaluate/test its risk management systems.
The company's executives and CEO are responsible for assessing and managing cybersecurity risks, but lack specific training or experience, so they rely on the expertise of the MSPs.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.